# Julianne Bruno

> Julianne Bruno is a post-ipo equity investor at Fairmount Funds Management backing Health Care. See 1 investments, check sizes, portfolio and contact…

- Type: Angel Investor
- Fund: [Fairmount Funds Management](https://shizune.co/investors/profile/fairmount-funds-management)
- Location: Boston, United States
- Total investments: 1
- Last investment: Nov 2025
- Lead investor: 100%
- Last updated: Oct 2026
- LinkedIn: https://www.linkedin.com/in/julianne-bruno-30448867
- X (Twitter): https://x.com/JulianneBrun07
- Facebook: https://www.facebook.com/julianne.bruno.1

Julianne Bruno is a post-ipo equity investor at Fairmount Funds Management in Boston focused on Health Care and Biotechnology. Julianne Bruno is the current Chief Operating Officer of CRISPR Therapeutics. She previously worked at McKinsey and Company as an Engagement Manager. Julianne Bruno attended The Wharton School.

## Contacts

5 contacts available for Julianne Bruno: work email, personal email, work phone, personal phone and socials. Sign up free to unlock them: https://app.shizune.co/sign-up/investor-profiles/find-email/julianne-bruno-36ca?utm_source=investor_profile

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Health Care | 1 | 100% |
| Biotechnology | 1 | 100% |
| Health Diagnostics | 1 | 100% |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| Galecto | Galecto develops small molecules for the treatment of severe diseases, including fibrosis and cancer. The company lead product candidate, GB0139, is an inhaled inhibitor of galectin-3. GB0139 is being developed for the treatment of severe fibrotic lung diseases such as idiopathic pulmonary fibrosis, or IPF, in which there is high unmet medicalneed. Galecto was founded in 2011, builds on more than 10 years of research centering on the role of galectin-3 and LOXL-2, and the use of modulators of these proteins to treat fibrosis-related diseases and cancer. Combined with a strong patent estate, these assets give Galecto a unique therapeutic platform. | $284.9M | Post-IPO Equity | Nov 10, 2025 | http://galecto.com/ |

1 of 1 investments shown.

## Co-investors
- [Forbion Capital Partners](https://shizune.co/investors/profile/forbion-capital-partners) — VC Fund, 1 deal together
- [Janus Henderson Investors](https://shizune.co/investors/profile/janus-henderson-investors) — VC Fund, 1 deal together
- [Perceptive Advisors](https://shizune.co/investors/profile/perceptive-advisors) — VC Fund, 1 deal together
- [RA Capital Management](https://shizune.co/investors/profile/ra-capital-management) — VC Fund, 1 deal together
- [TCG Crossover](https://shizune.co/investors/profile/tcg-crossover) — VC Fund, 1 deal together
- [Venrock Healthcare Capital Partners](https://shizune.co/investors/profile/venrock-healthcare-partners) — VC Fund, 1 deal together

## About Fairmount Funds Management

VC Fund · Philadelphia, United States

Fairmount Funds Management is a Philadelphia-based investment firm.

1 contacts available at Fairmount Funds Management.

| Name | Title | Profile |
| --- | --- | --- |
| Peter Harwin | Co-Founder and Managing Member | https://shizune.co/investors/profile/peter-harwin |

## Similar investors

### Similar stage
- [RA Capital Management](https://shizune.co/investors/profile/ra-capital-management) — VC Fund
- [KB Securities](https://shizune.co/investors/profile/kb-securities) — VC Fund
- [Frazier Healthcare Partners](https://shizune.co/investors/profile/frazier-healthcare-ventures) — VC Fund

## FAQ

### What does Julianne Bruno invest in?

Julianne Bruno invests primarily in Health Care, Biotechnology and Health Diagnostics startups, most often at Post-IPO Equity stage. Most of the 1 investments tracked by Shizune back companies in Denmark. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### How do I contact Julianne Bruno?

Public channels for Julianne Bruno include LinkedIn, X (Twitter) and Facebook. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.

### When did Julianne Bruno last invest?

The most recent investment recorded for Julianne Bruno closed in Nov 2025. Shizune tracks 1 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Oct 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co